These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9915781)

  • 1. Troponin I, stunning, hypertrophy, and failure of the heart.
    Solaro RJ
    Circ Res; 1999 Jan 8-22; 84(1):122-4. PubMed ID: 9915781
    [No Abstract]   [Full Text] [Related]  

  • 2. Heart failure, myocardial stunning, and troponin: a key regulator of the cardiac myofilament.
    Murphy AM
    Congest Heart Fail; 2006; 12(1):32-8; quiz 39-40. PubMed ID: 16470090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic aspects of cardiac hypertrophy and dilatation in normo- and hypertensive hemodialyzed patients.
    Cocchi A; Mori R; Carosella L; Iacono G; Greco A; Carbonin PU
    Contrib Nephrol; 1984; 41():288-91. PubMed ID: 6241133
    [No Abstract]   [Full Text] [Related]  

  • 4. [Heart failure: the electrophysiological connection. Myocardial stunning and heart failure: mechanisms in common?].
    Marbán E
    Rev Esp Cardiol; 2000; 53 Suppl 1():14-8. PubMed ID: 11007664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-terminal truncation of cardiac troponin I causes divergent effects on ATPase and force: implications for the pathophysiology of myocardial stunning.
    Foster DB; Noguchi T; VanBuren P; Murphy AM; Van Eyk JE
    Circ Res; 2003 Nov; 93(10):917-24. PubMed ID: 14551240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medicine in images. Case 2: Spectacular and early improvement of ventricular function after revascularization of hibernating myocardium].
    Nogales Asensio JM; Serrano Vicente J; Fuentes Cañamero ME; Rayo Madrid JI; Marzal Martín D
    Rev Clin Esp; 2005 May; 205(5):242, 245-6. PubMed ID: 15970158
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental and clinical studies of therapy and physiopathology of cardiac failure].
    Jpn Circ J; 1991; 55 Suppl 2():305-27. PubMed ID: 1833566
    [No Abstract]   [Full Text] [Related]  

  • 8. Repetitive stunning, hibernation, and heart failure: contribution of PET to establishing a link.
    Camici PG; Dutka DP
    Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H929-36. PubMed ID: 11179032
    [No Abstract]   [Full Text] [Related]  

  • 9. The contributions of cardiac myosin binding protein C and troponin I phosphorylation to β-adrenergic enhancement of in vivo cardiac function.
    Gresham KS; Stelzer JE
    J Physiol; 2016 Feb; 594(3):669-86. PubMed ID: 26635197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MR-tomography of the heart in cardiomegaly caused by dilated cardiomyopathy and ischemic heart disease].
    Sabekiia ON; Sinitsyn VE; Belenkov IuN; Mareev VIu
    Kardiologiia; 1991 Sep; 31(9):9-11. PubMed ID: 1836511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relation between myocardial hypertrophy, wall stress and left ventricular function in dilated cardiomyopathy].
    Shen WF; Gong LS; Chang FL
    Zhonghua Nei Ke Za Zhi; 1987 Dec; 26(12):695-7, 742. PubMed ID: 3451853
    [No Abstract]   [Full Text] [Related]  

  • 12. The heart in congestive failure.
    Katz AM
    Cardioscience; 1990 Mar; 1(1):3-6. PubMed ID: 2151711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiocirculatory regulation in heart hypertrophy].
    Dickhuth HH
    Fortschr Med; 1986 Jan; 104(3):38-42. PubMed ID: 2937702
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathophysiology of cardiac hypertrophy and failure of human working myocardium: abnormalities in calcium handling.
    Meuse AJ; Perreault CL; Morgan JP
    Basic Res Cardiol; 1992; 87 Suppl 1():223-33. PubMed ID: 1323261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Denolin lecture. Congestive heart failure: a half century perspective.
    Braunwald E
    Eur Heart J; 2001 May; 22(10):825-36. PubMed ID: 11350092
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan.
    García González MJ; Domínguez Rodríguez A
    Am J Cardiovasc Drugs; 2006; 6(2):69-75. PubMed ID: 16555860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy.
    Murphy RT; Mogensen J; Shaw A; Kubo T; Hughes S; McKenna WJ
    Lancet; 2004 Jan; 363(9406):371-2. PubMed ID: 15070570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial hypertrophy and cardiac failure: a complex interrelationship.
    Massie BM
    Am J Med; 1983 Sep; 75(3A):67-74. PubMed ID: 6226198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of troponin I proteolysis in the pathogenesis of stunned myocardium.
    Gao WD; Atar D; Liu Y; Perez NG; Murphy AM; Marban E
    Circ Res; 1997 Mar; 80(3):393-9. PubMed ID: 9048660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Power-velocity relations of isotonic relaxation in myocardial hypertrophy and insufficiency. Studies of isolated human ventricular myocardium].
    Strauer BE
    Z Kardiol; 1973 Mar; 62(3):220-7. PubMed ID: 4268211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.